Die Hu
- Marketing top 10%
- Strategy and Management top 10%
- Sustainable Supply Chain Management 2
-
- SARS-CoV-2 and COVID-19 Research 2
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
- RNA modifications and cancer 2
-
- Innovation Policy and R&D 2
-
- Oral microbiology and periodontitis research 2
-
- Immunotherapy and Immune Responses 2
Die Hu
18 papers receiving 325 citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Marketing 54
- Strategy and Management 83
- Management of Technology and Innovation 23
- Business and International Management 6
- Infectious Diseases 54
Countries citing papers authored by Die Hu
This map shows the geographic impact of Die Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Die Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Die Hu more than expected).
Fields of papers citing papers by Die Hu
This network shows the impact of papers produced by Die Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Die Hu. The network helps show where Die Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Die Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicinesbreakdown → | 2025 | 29 |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 26 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 27 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 36 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 41 | |
| 13 | 2020 | 8 | |
| 14 | 2020 | 23 | |
| 15 | 2018 | 51 | |
| 16 | 2017 | 37 | |
| 17 | 2016 | 2 | |
| 18 | 2015 | 30 | |
| 19 | 2015 | 1 |
About Die Hu
Die Hu is a scholar working on Periodontics, Biotechnology and Orthodontics, having authored 19 papers that have together received 336 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Innovation Policy and R&D (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Sustainable Supply Chain Management (2 papers), Oral microbiology and periodontitis research (2 papers), RNA modifications and cancer (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Marketing (54 citations), Strategy and Management (83 citations) and Management of Technology and Innovation (23 citations). Die Hu has collaborated with scholars based in China, Pakistan and Canada. Frequent co-authors include Yuandi Wang, Xue Yang, Yongqiang Gao, Yu Li, Yaomei Tian, Yuhua Li, Yang Li, Yusi Wang, Mohan Liu and Yiwei Li. Their work appears in journals such as Business Strategy and the Environment, Signal Transduction and Targeted Therapy, International Journal of Pharmaceutics, International Archives of Allergy and Immunology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.